---
title: "KTTAW.US (KTTAW.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KTTAW.US/news.md"
symbol: "KTTAW.US"
name: "KTTAW.US"
parent: "https://longbridge.com/en/quote/KTTAW.US.md"
datetime: "2026-05-20T15:35:03.274Z"
locales:
  - [en](https://longbridge.com/en/quote/KTTAW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KTTAW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KTTAW.US/news.md)
---

# KTTAW.US (KTTAW.US) — Related News

### [Pasithea Therapeutics Appoints Kartik Krishnan As CMO](https://longbridge.com/en/news/285065041.md)
*2026-05-04T11:37:26.000Z*
> Pasithea Therapeutics Corporation (KTTA) has appointed Kartik Krishnan as chief medical officer effective May 1. Krishna

### [Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer | KTTA Stock News](https://longbridge.com/en/news/285060592.md)
*2026-05-04T03:01:12.000Z*
> Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer | KTTA Stock News

### [Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) | KTTA Stock News](https://longbridge.com/en/news/283339980.md)
*2026-04-20T03:01:13.000Z*
> Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Ne

### [PASITHEA THERAPEUTICS CORP C/WTS 12/08/2026 (TO PUR COM) | 10-K: FY2025 Revenue: USD 0](https://longbridge.com/en/news/281080622.md)
*2026-03-30T21:47:23.000Z*
### [MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector](https://longbridge.com/en/news/279391543.md)
*2026-03-17T08:09:19.000Z*
> MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector

### [MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform](https://longbridge.com/en/news/276231424.md)
*2026-02-18T13:06:07.000Z*
> MindBio Therapeutics Corp. has announced the development of a proprietary edge computing platform for large-scale deploy